标题
Unraveling the Wide Spectrum of Melanoma Biomarkers
作者
关键词
-
出版物
Diagnostics
Volume 11, Issue 8, Pages 1341
出版商
MDPI AG
发表日期
2021-07-27
DOI
10.3390/diagnostics11081341
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
- (2021) Soudeh Ghafouri-Fard et al. Frontiers in Oncology
- Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
- (2021) Stergios Boussios et al. Annals of Translational Medicine
- Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
- (2021) Dekker C. Deacon et al. Frontiers in Medicine
- Current Molecular Markers of Melanoma and Treatment Targets
- (2020) Kevin Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
- (2020) Stergios Boussios et al. Drugs in research & development
- Uveal melanoma
- (2020) Martine J. Jager et al. Nature Reviews Disease Primers
- Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis
- (2020) Matias A. Bustos et al. Cancers
- Overcoming Immune Evasion in Melanoma
- (2020) Kevinn Eddy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RAGE Signaling in Melanoma Tumors
- (2020) Olamide T. Olaoba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Non-Coding Landscape of Cutaneous Malignant Melanoma: A Possible Route to Efficient Targeted Therapy
- (2020) Andreea D. Lazăr et al. Cancers
- Melanoma of unknown primary: New perspectives for an old story
- (2020) Stergios Boussios et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS ‐mutant melanoma
- (2019) Abdullah Al Emran et al. Cancer Medicine
- Molecular genomic profiling of melanocytic nevi
- (2019) Andrew J. Colebatch et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
- (2019) de Koning et al. Cancers
- Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives
- (2019) Croce et al. Cancers
- Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
- (2019) G V Long et al. ANNALS OF ONCOLOGY
- Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
- (2019) Stergios Boussios et al. INVESTIGATIONAL NEW DRUGS
- Prognostic Role of BRAFV600E Cellular Localization in Melanoma
- (2018) Zakaria Y. Abd Elmageed et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Punctuated evolution of canonical genomic aberrations in uveal melanoma
- (2018) Matthew G. Field et al. Nature Communications
- CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients
- (2018) Bruna Dalmasso et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- High response rate to PD-1 blockade in desmoplastic melanomas
- (2018) Zeynep Eroglu et al. NATURE
- BRAF fusions identified in melanomas have variable treatment responses and phenotypes
- (2018) Jacqueline A. Turner et al. ONCOGENE
- Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities
- (2018) Roy Rabbie et al. JOURNAL OF PATHOLOGY
- Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma
- (2017) Rachel D. Melamed et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- NRAS-mutant melanoma: current challenges and future prospect
- (2017) Eva Muñoz-Couselo et al. OncoTargets and Therapy
- DNA methylation/hydroxymethylation in melanoma
- (2017) Siqi Fu et al. Oncotarget
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
- (2017) Goran Micevic et al. Clinical Epigenetics
- The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics
- (2017) Chihao Shao et al. PLoS One
- Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
- (2016) Ting Shi et al. DISEASE MARKERS
- GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis
- (2016) Xinan Sheng et al. EUROPEAN JOURNAL OF CANCER
- Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
- (2016) Klaus G. Griewank et al. EUROPEAN JOURNAL OF CANCER
- GermlineCDKN2AMutation Status and Survival in Familial Melanoma Cases
- (2016) Hildur Helgadottir et al. JNCI-Journal of the National Cancer Institute
- Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
- (2016) Georgina V Long et al. LANCET ONCOLOGY
- GNA11 Mutation in a Patient With Cutaneous Origin Melanoma
- (2016) Sapna P. Patel et al. MEDICINE
- Prognostic and predictive value of YKL-40 in stage IIB-III melanoma
- (2016) Merete Krogh et al. MELANOMA RESEARCH
- GermlineCDKN2AMutation Status and Survival in Familial Melanoma Cases
- (2016) Hildur Helgadottir et al. JNCI-Journal of the National Cancer Institute
- NF1 Mutations Are Common in Desmoplastic Melanoma
- (2015) Thomas Wiesner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Melanoma: Advances in Targeted Therapy and Molecular Markers
- (2015) Danielle K. DePeralta et al. ANNALS OF SURGICAL ONCOLOGY
- Treatment of NRAS-Mutant Melanoma
- (2015) Douglas B. Johnson et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Prognostic score for patients with advanced melanoma treated with ipilimumab
- (2015) Stefan Diem et al. EUROPEAN JOURNAL OF CANCER
- Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation
- (2015) Martin Lauss et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Histologic features of melanoma associated with CDKN2A genotype
- (2015) Michael R. Sargen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prognostic and predictive values of oncogenicBRAF, NRAS, c-KITandMITFin cutaneous and mucous melanoma
- (2015) M. Pracht et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
- (2015) A Hunter Shain et al. NATURE GENETICS
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containingBRAFkinase fusion
- (2015) Alexander M. Menzies et al. Pigment Cell & Melanoma Research
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
- (2015) Elin S. Gray et al. Oncotarget
- BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
- (2015) Caterina Chiappetta et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- (2015) Nancy E. Thomas et al. JAMA Oncology
- Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
- (2015) Fubo Wang et al. Oncotarget
- Desmoplastic Melanoma With Sarcomatoid Dedifferentiation
- (2014) Maija Kiuru et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma
- (2014) Muhammad Nauman Aftab et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
- (2014) H Kalirai et al. BRITISH JOURNAL OF CANCER
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Loss of NF1 in Cutaneous Melanoma Is Associated with RAS Activation and MEK Dependence
- (2014) Moriah H. Nissan et al. CANCER RESEARCH
- Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
- (2014) M. F. Sanmamed et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling
- (2014) Miriam Potrony et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- MEK targeting in N-RAS mutated metastatic melanoma
- (2014) Jaykumar Thumar et al. Molecular Cancer
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- The landscape of kinase fusions in cancer
- (2014) Nicolas Stransky et al. Nature Communications
- Melanoma: Clinical Features and Genomic Insights
- (2014) E. B. Hawryluk et al. Cold Spring Harbor Perspectives in Medicine
- Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
- (2013) A E Koopmans et al. BRITISH JOURNAL OF CANCER
- Navigating the Therapeutic Complexity of PI3K Pathway Inhibition in Melanoma
- (2013) L. N. Kwong et al. CLINICAL CANCER RESEARCH
- NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi
- (2013) Christelle Charbel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Plasma osteopontin concentrations in patients with cutaneous melanoma
- (2013) A. FILIA et al. ONCOLOGY REPORTS
- Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy
- (2013) Thomas Botton et al. Pigment Cell & Melanoma Research
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
- (2012) A. M. Menzies et al. CLINICAL CANCER RESEARCH
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- Familial Melanoma–Associated Mutations in p16 Uncouple its Tumor-Suppressor Functions
- (2012) Noah C. Jenkins et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serum microRNAs as biomarkers for recurrence in melanoma
- (2012) Erica B Friedman et al. Journal of Translational Medicine
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Secreted microRNAs: a new form of intercellular communication
- (2012) Xi Chen et al. TRENDS IN CELL BIOLOGY
- Elucidating Distinct Roles for NF1 in Melanomagenesis
- (2012) Ophélia Maertens et al. Cancer Discovery
- Plasma Markers for Identifying Patients with Metastatic Melanoma
- (2011) H. M. Kluger et al. CLINICAL CANCER RESEARCH
- Association of galectin-3 expression with melanoma progression and prognosis
- (2011) Ewan R. Brown et al. EUROPEAN JOURNAL OF CANCER
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Osteopontin expression in plasma of melanoma patients and in melanocytic tumours
- (2011) T. Maier et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
- (2011) Bianca Devitt et al. Pigment Cell & Melanoma Research
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the RAS pathway in melanoma
- (2011) Zhenyu Ji et al. TRENDS IN MOLECULAR MEDICINE
- The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells
- (2010) Heike Niessner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prognostic value of galectin-3 in primary cutaneous melanoma
- (2010) M. Buljan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Aberrant DNA methylation in malignant melanoma
- (2010) Carolina Schinke et al. MELANOMA RESEARCH
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers in melanoma
- (2009) H. Gogas et al. ANNALS OF ONCOLOGY
- DNA methylation of cancer genome
- (2009) Hoi-Hung Cheung et al. BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
- (2009) C Alfaro et al. BRITISH JOURNAL OF CANCER
- Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
- (2009) W. K. Nevala et al. CLINICAL CANCER RESEARCH
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Molecular Markers of Tumor Progression in Melanoma
- (2009) Joshua Rother et al. CURRENT GENOMICS
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- COX-2 expression in malignant melanoma: a novel prognostic marker?
- (2009) Maria R. Becker et al. MELANOMA RESEARCH
- Cyclooxygenase-2 immunohistochemistry in human melanoma: differences between results obtained with different antibodies
- (2009) Łukasz Kużbicki et al. MELANOMA RESEARCH
- Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma
- (2008) Agop Y. Bedikian et al. CANCER INVESTIGATION
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- (2008) C. Montagut et al. CANCER RESEARCH
- Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
- (2008) Sandra S. McAllister et al. CELL
- The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis
- (2008) Simone Mocellin et al. INTERNATIONAL JOURNAL OF CANCER
- Short German guidelines: Malignant melanoma
- (2008) Claus Garbe et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- The RASSF1A Tumor Suppressor Restrains Anaphase-Promoting Complex/Cyclosome Activity during the G1/S Phase Transition To Promote Cell Cycle Progression in Human Epithelial Cells
- (2008) A. W. Whitehurst et al. MOLECULAR AND CELLULAR BIOLOGY
- Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
- (2008) Jose Lutzky et al. Pigment Cell & Melanoma Research
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib
- (2008) Alfonso Quintás-Cardama et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search